DePuy Synthes to acquire assets of JointPoint Inc for hip replacement navigation software

Johnson & Johnson Medical Devices Companies announced DePuy Synthes Products Inc. has signed a definitive agreement to acquire navigation software to improve surgical outcomes in hip replacement from JointPoint Inc., according to a company press release.

“JointPoint ties into our strategy to transform hip replacement and is specifically designed for use with the anterior approach, a tissue-sparing surgical technique which surgeons are increasingly utilizing and where we have long had an industry-leading presence,” Aaron Villaruz, vice president and global platform leader of hips at DePuy Synthes, said in the release.

According to the release, DePuy Synthes had a co-marketing agreement since July of 2017 to market the JointPoint platform in the United States. At the close of the transaction, the JointPoint platform will become part of the anterior advantage solution of DePuy Synthes, which is called the Anterior Advantage, and includes DePuy Synthes implants and instrumentation, technologies that optimize patient surgery, and an education program to reduce the learning curve and increase surgical reproducibility. The transaction is subject to customary closing conditions and is expected to close this year.

 

Reference:

www.jnjmedicaldevices.com/en-US

 

Johnson & Johnson Medical Devices Companies announced DePuy Synthes Products Inc. has signed a definitive agreement to acquire navigation software to improve surgical outcomes in hip replacement from JointPoint Inc., according to a company press release.

“JointPoint ties into our strategy to transform hip replacement and is specifically designed for use with the anterior approach, a tissue-sparing surgical technique which surgeons are increasingly utilizing and where we have long had an industry-leading presence,” Aaron Villaruz, vice president and global platform leader of hips at DePuy Synthes, said in the release.

According to the release, DePuy Synthes had a co-marketing agreement since July of 2017 to market the JointPoint platform in the United States. At the close of the transaction, the JointPoint platform will become part of the anterior advantage solution of DePuy Synthes, which is called the Anterior Advantage, and includes DePuy Synthes implants and instrumentation, technologies that optimize patient surgery, and an education program to reduce the learning curve and increase surgical reproducibility. The transaction is subject to customary closing conditions and is expected to close this year.

 

Reference:

www.jnjmedicaldevices.com/en-US